Novo Nordisk A S NVO
NYSE NVO
$40.31 +0.04 (+0.10%)
At close: Nov 6, 2026 · 4:00 PM EST

Novo Nordisk A S (NVO) Cost of Revenue (2012 - 2017)

Updated

Novo Nordisk A S (NVO) recorded Cost of Revenue of $20.09 billion in Q4 2019.

Analysis

Novo Nordisk A S (NVO) Cost of Revenue (2012 - 2017) Analysis & Trends

On a TTM basis, Novo Nordisk A S's Cost of Revenue came in at $22.17 billion as of Dec 31, 2019; for FY2016, it was $20.01 billion.

  • Annual Cost of Revenue has a five-year compound annual growth rate of 9.7% (FY2011 to FY2016).
  • Across earlier years, Cost of Revenue came in at $14.14 billion in FY2013 (+5.0%) and $13.47 billion in FY2012 (+7.0%).
  • The Q4 2019 figure is the highest quarterly Cost of Revenue since Q4 2015.
  • Peak year-over-year performance for Cost of Revenue in the last five years was growth of 22.3% in Q4 2015, against a decline of 99.3% in Q4 2016 at the low end.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 740.00 Mn
Sep 30, 2017 672.00 Mn
Jun 30, 2017 651.00 Mn
Mar 31, 2017 608.00 Mn
Dec 31, 2016 715.00 Mn
Sep 30, 2016 598.00 Mn
Jun 30, 2016 614.00 Mn
Mar 31, 2016 625.00 Mn
Dec 31, 2015 104.37 Bn
Sep 30, 2015 573.00 Mn
Jun 30, 2015 570.00 Mn
Mar 31, 2015 586.00 Mn
Dec 31, 2014 85.34 Bn
Sep 30, 2014 608.00 Mn
Jun 30, 2014 674.00 Mn
Mar 31, 2014 637.00 Mn
Dec 31, 2013 620.00 Mn
Sep 30, 2013 626.00 Mn
Jun 30, 2013 632.00 Mn
Mar 31, 2013 639.00 Mn
API Access

Novo Nordisk A S Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=NVO&period=max&api_key=YOUR_API_KEY